Kardigan launches with cozy $300M, late-stage portfolio

Jan 10, 2025  · Kardigan launches with cozy $300M series A and collection of late-stage cardio assets By Darren Incorvaia Jan 10, 2025 1:18pm cardiovascular disease series A MyoKardia …


Install CouponFollow Chrome Extension   CouponFollow Extension

$300
OFF

Kardigan Launches With Cozy $300M, Late-stage Portfolio

2 weeks from now

Jan 10, 2025  · Kardigan launches with cozy $300M series A and collection of late-stage cardio assets By Darren Incorvaia Jan 10, 2025 1:18pm cardiovascular disease series A MyoKardia …

fiercebiotech.com

$300
OFF

Kardigan Launches With $300 Million Series A To Transform ...

2 weeks from now

Jan 13, 2025  · Amy Westfall, vice president, portfolio and project management; In addition, Kardigan has assembled an industry-leading board of directors spanning notable scientists, …

biopharmaboardroom.com

$300
OFF

MyoKardia Alumni Launch Kardigan With $300M To Tackle Heart …

2 weeks from now

Jan 10, 2025  · Capping off a flurry of mega-round launches this week, Kardigan debuted Friday with an all-star cast and an ambitious mission: to unseat cardiovascular disease as the leading …

biospace.com

$300
OFF

Kardigan Debuts With $300M And Visionary Team To Revolutionize ...

2 weeks from now

San Francisco & Princeton, NJ, January 10, 2025 (Business Wire) -- Kardigan launches with $300 million in funding and a mission to cure and prevent cardiovascular disease, led by Tassos …

jacobsmgt.com

$300
OFF

Kardigan Raises $300m For Cardio Work, And Other Financings

2 weeks from now

Jan 31, 2025  · Formed by former executives from MyoKardia – bought by Bristol Myers Squibb for $13.1 billion in 2020 – Kardigan says it has already curated a portfolio of "late-stage clinical …

pharmaphorum.com

$300
OFF

Kardigan Launches With Cozy $300M Series A And Collection Of Late …

2 weeks from now

Launching with $300 million in hand, Kardigan plans to develop paral Kardigan launches with cozy $300M series A and collection of late-stage cardio assets - NewsBreak Open in App

newsbreak.com

$300
OFF

Kardigan Launches With Cozy $300M Series A And Collection Of Late …

2 weeks from now

Jan 11, 2025  · A new company is making its debut with a series A sum that’s sure to make hearts race.Launching with $300 million in hand, Kardigan plans to develop parallel treatments to …

sfbn.org

$300000000
OFF

Kardigan Raises $300,000,000 At Series A On 2025-01-14 - Founder …

2 weeks from now

Jan 14, 2025  · Kardigan raises $300,000,000 at Series A on 2025-01-14 in Biotechnology Research, industry founded/co-founded by Tassos Gianakakos. Daily News; ... Kardigan is …

founderlodge.com

$300
OFF

Kardigan (USA) Funding: $300M - Medicalstartups.org

2 weeks from now

Jan 14, 2025  · Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom …

medicalstartups.org

$1
OFF

Home - Blackstone

2 weeks from now

Our scale – with ~12,600 real estate assets and 250 portfolio companies [1] – enables us to invest in dynamic sectors positioned for long-term growth. Learn More. $1.1T. Assets Under …

blackstone.com

FAQs about Kardigan launches with cozy $300M, late-stage portfolio Coupon?

What is a kardigan series a?

A new company is making its debut with a series A sum that’s sure to make hearts race. Launching with $300 million in hand, Kardigan plans to develop parallel treatments to prevent and cure cardiovascular diseases so that they’re no longer the leading cause of death worldwide, the company announced in a Jan. 10 release. ...

Why is kardigan developing new medicines?

Cardiovascular disease is the leading cause of death in the world. We are developing novel medicines to change that. Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. ...

What does kardigan do?

By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve. For more information about Kardigan, please visit kardigan.bio. ...

How much money does kardigan invest in?

In addition to our accomplished team of executives and industry-leading board of directors, Kardigan launches with $300 million in Series A capital from a strong investor syndicate that includes Perceptive Advisors, ARCH Venture Partners, and Sequoia Heritage. ...

Where can I find more information about kardigan?

For more information about Kardigan, please visit kardigan.bio. If you are interested in joining our passionate and driven team with deep cardiovascular, biotechnology and operational expertise, please visit kardigan.bio or the careers tab of this page. ...

What is kardigan's mission?

Capping off a flurry of mega-round launches this week, Kardigan debuted Friday with an all-star cast and an ambitious mission: to unseat cardiovascular disease as the leading cause of death worldwide. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension